ImageneBio Inc. Company Profile
NASDAQ: IMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ImageneBio at a glance
ImageneBio Inc. (NASDAQ: IMA) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in San Diego, CA. ImageneBio is led by Dr. Kristin Yarema Ph.D. and employs about 18 people. The company's shares have traded publicly since 2021.
At a market capitalization of $49.6 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001835579, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does ImageneBio do?
ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
Business description based on the company's public filings.
Company information
- Legal name
- ImageneBio Inc.
- Ticker
- NASDAQ: IMA
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Dr. Kristin Yarema Ph.D.
- Employees
- 18
- Headquarters
- 12526 High Bluff Drive, San Diego, CA, United States
- Phone
- 858 345 6265
- Website
- inmagenebio.com
- IPO year
- 2021
- Market cap
- $49.58M
- SEC CIK
- 0001835579
- Latest annual report
- 10-K · Mar 10, 2026
Companies similar to ImageneBio
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AVXLAnavex Life Sciences Corp. | 0.5915 | -11.39% | $54.83M | vs IMA |
| GRMLGreenland Mines Ltd. | 2.99 | +2.75% | $44.31M | vs IMA |
| CGTXCognition Therapeutics Inc. | 0.5822 | -3.06% | $55.37M | vs IMA |
| ELOXEloxx Pharmaceuticals Inc. | 10.69 | -1.75% | $43.69M | vs IMA |
| OKYOOKYO Pharma Limited | 1.07 | -7.76% | $56.15M | vs IMA |
| CHRSCoherus Oncology Inc. | 0.3698 | -4.47% | $57.15M | vs IMA |
| INKTMiNK Therapeutics Inc. | 8.02 | -6.85% | $41.17M | vs IMA |
| ELUTElutia Inc. Class A | 0.9001 | +11.12% | $39.96M | vs IMA |